Cash Flow Statement
Growth Metrics

Orthofix Medical (OFIX) Equity Ratio (2016 - 2026)

Orthofix Medical has reported Equity Ratio over the past 17 years, most recently at 0.49 for Q1 2026.

  • For the quarter ending Q1 2026, Equity Ratio fell 11.84% year-over-year to 0.49, compared with a TTM value of 0.49 through Mar 2026, down 11.84%, and an annual FY2025 reading of 0.53, down 6.07% over the prior year.
  • Equity Ratio came in at 0.49 for Q1 2026, down from 0.53 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.74 in Q3 2022 to a low of 0.49 in Q1 2026.
  • Median Equity Ratio over the past 5 years was 0.63 (2024), compared with a mean of 0.63.
  • The sharpest move saw Equity Ratio rose 5.2% in 2022, then dropped 13.08% in 2024.
  • Over 5 years, Equity Ratio stood at 0.73 in 2022, then fell by 11.9% to 0.65 in 2023, then dropped by 12.96% to 0.56 in 2024, then fell by 6.07% to 0.53 in 2025, then fell by 7.22% to 0.49 in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Equity Ratio are 0.49 (Q1 2026), 0.53 (Q4 2025), and 0.53 (Q3 2025).